Pharmacogenetic profiles of young danish individuals with and without severe mental disorders
Introduction Pharmacogenetics (PGx) studies genetic variance and related differences in drug outcomes. PGx guidelines for psychotropic drugs are available (PGx drugs). By executing PGx testing in a prospective or pre-emptive setting, dose adjustments or even change of treatment type can be applied...
Main Authors: | C. Lunenburg, J. Thirstrup, C. Gasse |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821003965/type/journal_article |
Similar Items
-
Pharmacogenetic drug use in young danish individuals with severe mental disorders
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
by: M. Mushtaq, et al.
Published: (2022-06-01) -
Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review
by: Emiliene B. Tata, et al.
Published: (2020-08-01) -
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
by: A. Bignucolo, et al.
Published: (2023-05-01)